Evidence map›Paper›PMID 42327087›Full record

ArticlebioRxiv : the preprint server for biology2026

Lineage-specific chromatin poising enforced by ETS-IRF composite elements determines the divergent interferon responses of plasmacytoid dendritic cells and epithelial cells.

Gargi Mishra, Snehal Ozarkar, Yo Okamura, Meghan Knoll, Russell Sam, Hongchuan Li, Johannes Schwerk, Adelle P McFarland, David Constant, Hayley Waterman and 12 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Gargi MishraDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0003-1905-3519
Snehal OzarkarDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.
Yo OkamuraDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.
Meghan KnollDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0009-0000-9605-2750
Russell SamDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.
Hongchuan LiBasic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-3501-4299
Johannes SchwerkDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-5964-7162
Adelle P McFarlandDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0001-7534-1158
David ConstantOregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0001-9656-078X
Hayley WatermanCentre for Fundamental Immunology, Benaroya Research Institute, Seattle, WA, USA.
Manasa AcharyaDepartment of Microbiology, University of Washington, Seattle, WA, USA.ORCID 0000-0003-4545-7402
Adam Lacy-HulbertCentre for Fundamental Immunology, Benaroya Research Institute, Seattle, WA, USA.
Jason G SmithDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Michael ParthunDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Emily HemannDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA.ORCID 0000-0002-6398-3492
Isaac M Barber-AxthelmDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-7892-6802
Weiming LiDepartment of Pediatrics (Cardiology), University of Washington, Seattle, WA, USA; Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA.
Vishal NigamDepartment of Pediatrics (Cardiology), University of Washington, Seattle, WA, USA; Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA.
Timothy NiceOregon Health & Science University, Portland, Oregon, USA.
Jessica A HammermanCentre for Fundamental Immunology, Benaroya Research Institute, Seattle, WA, USA.ORCID 0000-0001-5864-5299
Stephen K AndersonBasic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-7856-4266
Ram SavanDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-3087-1355

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
Novel regulatory mechanisms control IFNL3 expression during HCV infectionR01AI108765 · NIAID · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2014 to 2018
$2.3M
RIG-I-like receptor regulation of pulmonary inflammation and homeostasisR35GM150503 · NIGMS · OHIO STATE UNIVERSITY · PI Emily Ann Hemann · 2023 to 2026
$1.6M
Interdisciplinary Program in Microbe-Host BiologyT32AI165391 · NIAID · OHIO STATE UNIVERSITY · PI RAJENDAR K DEORA, Daniel J Wozniak · 2022 to 2026
$1.5M
Functional diversity of zinc finger antiviral protein isoforms during viral infectionR21AI135437 · NIAID · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2018 to 2019
$484k
Functional insights into the IRF5 genetic variants marking SLE risk.R21AR067980 · NIAMS · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2015 to 2016
$441k
NIAID NIH HHS R01 AI108765NIAID NIH HHS R21 AI135437NIAID NIH HHS T32 AI165391NIAMS NIH HHS R21 AR067980NIGMS NIH HHS R35 GM150503NIH HHS 75N91019D00024
6 · The paper itself

Abstract

Plasmacytoid dendritic cells (pDCs) produce robust type I interferons (IFN-I) within hours of viral sensing, while epithelial cells at mucosal surfaces mount a delayed response dominated by type III interferons (IFN-III). Both cell types express pattern recognition receptors that activate similar downstream transcription factors, yet they produce distinct subsets of IFNs. The mechanisms underlying these differences have remained unclear. Here, using Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) in primary human pDCs and intestinal epithelial cells, we show that IFN-I and IFN-III gene loci carry opposing, constitutively established chromatin accessibility landscapes that determine cell-type-specific interferon induction. The IFN-I locus is broadly open in pDCs and constitutively closed in epithelial cells, while the IFN-III locus displays the reciprocal pattern. Motif enrichment analysis of accessible regions at the IFN-I locus in pDCs revealed unexpected and significant enrichment of ETS family binding motifs alongside IRF motifs, which determines the cell-type-specific locus accessibility. The ETS factor PU.1 and IRF8 bind IFN-I promoters, at composite ETS-IRF elements positioned at the Positive Regulatory Domain IV (PRDIV) site of

Identifiers

PMID42327087
PMCPMC13278087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.